The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Wed, 20th Jul 2016 15:06

UK Earnings, Trading Statements Calendar 
Thursday, July 21 
EasyjetQ3 Results
UnileverHalf Year Results
SABMillerTrading Statement 
SSETrading Statement 
Babcock International GroupTrading Statement 
Tate & LyleTrading Statement 
Close Brothers GroupTrading Statement 
BritvicTrading Statement 
AO WorldTrading Statement 
Hochschild MiningQ2 Production Results
Intermediate Capital GroupTrading Statement 
Hilton Food GroupTrading Statement 
Empresaria GroupTrading Statement 
WH IrelandHalf Year Results
Euromoney Institutional InvestorTrading Statement 
Breedon AggregatesTrading Statement 
Daily Mail & General TrustTrading Statement 
Fuller Smith & TurnerTrading Statement 
HalmaTrading Statement 
Howden Joinery Group Trading Statement 
Nichols Trading Statement 
Premier FoodsTrading Statement 
De La RueTrading Statement 
Friday, July 22 
Vodafone Group Trading Statement 
Accrol Group HoldingsFull Year Results
Big Yellow GroupTrading Statement 
BeazleyHalf Year Results
RecordTrading Statement 
Acacia Mining Half Year Results
KCOM GroupTrading Statement 
Alliance TrustHalf Year Results
Hogg Robinson GroupTrading Statement 
Monday, July 25 
XP PowerHalf Year Results
Ryanair HoldingsQ1 Results
Petra DiamondsTrading Statement 
CranswickTrading Statement 
TungstenFull Year Results
Aberdeen Asset ManagementTrading Statement 
HammersonHalf Year Results
GoodwinFull Year Results
HiscoxHalf Year Results
Tuesday, July 26 
BPQ2 Results
Provident FinancialHalf Year Results
GKNHalf Year Results
Virgin Money HoldingsHalf Year Results
PZ CussonsFull Year Results
SegroHalf Year Results
Brewin Dolphin HoldingsTrading Statement
Man GroupHalf Year Results
Capital & Counties PropertiesHalf Year Results
AcalTrading Statement
Victoria Full Year Results
Croda InternationalHalf Year Results
VictrexTrading Statement
Sage GroupTrading Statement
VolexTrading Statement
Fevertree DrinksHalf Year Results
Drax GroupHalf Year Results
Games Wrrkshop GroupFull Year Results
Jardine Lloyd Thompson GroupHalf Year Results
TymanHalf Year Results
Unite GroupHalf Year Results
HuntsworthHalf Year Results
VPTrading Statement 
Wednesday, July 27 
3i GroupTrading Statement 
ITVHalf Year Results
Taylor WimpeyHalf Year Results
AntofagastaQ2 Productio Results
CapitaHalf Year Results
ARM HoldingsHalf Year Results
St James's PlaceHalf Year Results
GlaxoSmithKlineHalf Year Results (at 1200 BST)
Jupiter Fund ManagementHalf Year Results
Smurfit Kappa GroupHalf Year Results
RightmoveHalf Year Results
DignityHalf Year Results
Mitchells & ButlersTrading Statement 
Tullow OilHalf Year Results
Metro BankHalf Year Results
RenishawHalf Year Results
Primary Health PropertiesHalf Year Results
Staffline GroupHalf Year Results
Flybe GroupTrading Statement 
Marston'sTrading Statement 
Morgan Advanced MaterialsHalf Year Results
Burford CapitalHalf Year Results
McColl's Retail GroupHalf Year Results
Rathbone BrothersHalf Year Results
Shawbrook GroupHalf Year Results
FDM GroupHalf Year Results
Lancashire HoldingsHalf Year Results
Law DebentureHalf Year Results
Tarsus GroupHalf Year Results
  
Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.